Charter Oak Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-87
Closed -$42K 361
2022
Q2
$42K Hold
87
0.01% 352
2022
Q1
$43K Hold
87
0.01% 379
2021
Q4
$40K Hold
87
﹤0.01% 393
2021
Q3
$32K Buy
87
+12
+16% +$4.56K ﹤0.01% 387
2021
Q2
$29K Sell
75
-236
-76% -$90.2K ﹤0.01% 392
2021
Q1
$112K Hold
311
0.02% 224
2020
Q4
$100K Buy
+311
New +$95.4K 0.02% 224

Other funds holding ELV

Charter Oak Capital Management's ELV Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 87 shares — an estimated $42K sold.

Charter Oak Capital Management first reported a position in ELV in Q4 2020 and held it in 7 quarters. The position peaked at $112K in Q1 2021. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 87 Elevance Health shares in Q3 2022, an estimated $42K.
  • Charter Oak Capital Management first reported a position in Elevance Health in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's Elevance Health position peaked at $112K in Q1 2021.
  • 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.